Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women

Clinical trial NCT05367973 · COMPLETED

Trial details

NCT number: NCT05367973
Sponsor: Daré Bioscience, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Vulvovaginal Atrophy Vasomotor Symptoms

Start date: 2022-04-11
Primary completion: 2023-01-09
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.